Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapy Meeting Abstract
| Authors: | Liu, S. V.; De Braud, F.; Drilon, A.; Doebele, R. C.; Patel, M. R.; Cho, B. C.; Ahn, M. J.; Chiu, C. H.; Farago, A. F.; Goto, K.; Lee, J.; Ohe, Y.; Ou, S. H. I.; Cassier, P.; Tan, D. S. W.; Otterson, G. A.; Veronese, L.; Osborne, S.; Simmons, B.; Siena, S. |
| Abstract Title: | Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapy |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S472 |
| End Page: | S473 |
| Language: | English |
| ACCESSION: | WOS:000573469100538 |
| DOI: | 10.1016/j.annonc.2020.08.654 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 540P -- Corrigendum issued, see DOI: 10.1016/j.annonc.2021.01.008 -- Source: Wos |
